27840085|t|Lowering the overall charge on TMPyP4 improves its selectivity for G-quadruplex DNA
27840085|a|Ligands that stabilize non-canonical DNA structures called G-quadruplexes (GQs) might have applications in medicine as anti-cancer agents, due to the involvement of GQ DNA in a variety of cancer-related biological processes. Five derivatives of 5,10,15,20-tetrakis(N-methyl-4-pyridyl)porphyrin (TMPyP4), where a N-methylpyridyl group was replaced with phenyl (4P3), 4-aminopheny l (PN3M), 4-phenylamidoproline (PL3M), or 4-carboxyphenyl (PC3M and P2C2M) were investigated for their interactions with human telomeric DNA (Tel22) using fluorescence resonance energy transfer (FRET) assay, and UV-visible and circular dichroism spectroscopies in K(+) buffer. The molecules are cationic or zwitterionic with an overall charge of 3+ (4P3, PN3M, and PL3M), 2+ (PC3M) or neutral (P2C2M). All porphyrins except P2C2M stabilize human telomeric DNA in FRET assays by ∼20 °C at 5 eq CD melting experiments suggest that 4P3 is the most stabilizing ligand with a stabilization temperature of 16.8 °C at 4 eq. Importantly, 4P3, PC3M and PL3M demonstrate excellent selectivity for quadruplexes, far superior to that of TMPyP4. Binding constants, determined using UV-vis titrations, correlate with charge: triply cationic 4P3, PN3M and PL3M display Ka of 5-9 μM(-1), doubly cationic PC3M displays Ka of 1 μM(-1), and neutral P2C2M displays weak-to-no binding. UV-vis data suggest that binding interactions are driven by electrostatic attractions and that the binding mode may be base-stacking (or end-stacking) judging by the high values of red shift (15-20 nm) and hypochromicity (40-50%). We conclude that lowering the charge on TMPyP4 to 3+ can achieve the desired balance between stabilizing ability, affinity, and high selectivity required for an excellent quadruplex ligand.
27840085	0	8	Lowering	T052	C2003888
27840085	31	37	TMPyP4	T109,T121	C0076211
27840085	51	62	selectivity	T052	C1707391
27840085	67	83	G-quadruplex DNA	T086	C1956090
27840085	84	91	Ligands	T103	C0023688
27840085	97	106	stabilize	T080	C0205360
27840085	121	135	DNA structures	T114	C1511699
27840085	143	157	G-quadruplexes	T086	C1517336
27840085	159	162	GQs	T086	C1517336
27840085	191	199	medicine	T121	C0013227
27840085	203	221	anti-cancer agents	T109,T121	C0003392
27840085	249	255	GQ DNA	T086	C1956090
27840085	272	286	cancer-related	T033	C2826292
27840085	287	307	biological processes	T038	C3714634
27840085	329	377	5,10,15,20-tetrakis(N-methyl-4-pyridyl)porphyrin	T109,T121	C0076211
27840085	379	385	TMPyP4	T109,T121	C0076211
27840085	396	417	N-methylpyridyl group	T104	C1254350
27840085	436	442	phenyl	T104	C1254350
27840085	444	447	4P3	T121	C1254351
27840085	450	462	4-aminopheny	T104	C1254350
27840085	466	470	PN3M	T121	C1254351
27840085	473	493	4-phenylamidoproline	T104	C1254350
27840085	495	499	PL3M	T121	C1254351
27840085	505	520	4-carboxyphenyl	T104	C1254350
27840085	522	526	PC3M	T121	C1254351
27840085	531	536	P2C2M	T121	C1254351
27840085	566	578	interactions	T044	C0687133
27840085	584	589	human	T016	C0086418
27840085	590	603	telomeric DNA	T026	C0085187
27840085	605	610	Tel22	T086	C0314659
27840085	618	656	fluorescence resonance energy transfer	T059	C0597717
27840085	658	662	FRET	T059	C0597717
27840085	675	685	UV-visible	T070	C1883416
27840085	690	723	circular dichroism spectroscopies	T070	C1519445
27840085	727	738	K(+) buffer	T121,T130	C0006353
27840085	744	753	molecules	T167	C0567416
27840085	758	766	cationic	T104	C0007447
27840085	813	816	4P3	T121	C1254351
27840085	818	822	PN3M	T121	C1254351
27840085	828	832	PL3M	T121	C1254351
27840085	839	843	PC3M	T121	C1254351
27840085	857	862	P2C2M	T121	C1254351
27840085	869	879	porphyrins	T109,T123	C0032712
27840085	887	892	P2C2M	T121	C1254351
27840085	903	908	human	T016	C0086418
27840085	909	922	telomeric DNA	T026	C0085187
27840085	926	937	FRET assays	T059	C0597717
27840085	956	978	CD melting experiments	T059	C0022885
27840085	992	995	4P3	T121	C1254351
27840085	1020	1026	ligand	T103	C0023688
27840085	1093	1096	4P3	T121	C1254351
27840085	1098	1102	PC3M	T121	C1254351
27840085	1107	1111	PL3M	T121	C1254351
27840085	1134	1145	selectivity	T052	C1707391
27840085	1150	1162	quadruplexes	T086	C1956090
27840085	1188	1194	TMPyP4	T109,T121	C0076211
27840085	1196	1213	Binding constants	T081	C0392762
27840085	1232	1249	UV-vis titrations	T059	C0022885
27840085	1274	1293	triply cationic 4P3	T121	C1254351
27840085	1295	1299	PN3M	T121	C1254351
27840085	1304	1308	PL3M	T121	C1254351
27840085	1335	1355	doubly cationic PC3M	T121	C1254351
27840085	1393	1398	P2C2M	T121	C1254351
27840085	1408	1418	weak-to-no	T080	C1762617
27840085	1419	1426	binding	T045	C1148673
27840085	1428	1439	UV-vis data	T078	C1511726
27840085	1453	1473	binding interactions	T045	C1148673
27840085	1488	1513	electrostatic attractions	T067	C2348396
27840085	1527	1534	binding	T045	C1148673
27840085	1547	1560	base-stacking	T067	C0596970
27840085	1565	1577	end-stacking	T067	C0596970
27840085	1634	1648	hypochromicity	T081	C1547008
27840085	1676	1684	lowering	T052	C2003888
27840085	1699	1705	TMPyP4	T109,T121	C0076211
27840085	1752	1771	stabilizing ability	T080	C0205360
27840085	1773	1781	affinity	T070	C1510827
27840085	1792	1803	selectivity	T052	C1707391
27840085	1830	1840	quadruplex	T086	C1956090
27840085	1841	1847	ligand	T103	C0023688